Vertex Pharmaceuticals (CH) GmbH - Orkambi 100 mg / 125 mg, Filmtabletten | | 65981 | | 02 | | Orkambi 100 mg / 125 mg | | Filmtabletten | | R07AX30 | | | | 19.04.2018 | | |
| Composition | lumacaftorum 100 mg, ivacaftorum 125 mg, hypromellosi acetas succinas, natrii laurilsulfas, cellulosum microcristallinum, carmellosum natricum conexum, povidonum K 30, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 120, E 132, E 133, E 171, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum pro compresso obducto corresp. natrium 2.56 mg. | Packungsbestandteile | | Comprimés filmés | | | Principe actif | Concentr. |
---|
| 125 mg | | 100 mg |
| BAG: Principe actif | Concentr. |
---|
| 125 mg | | 100 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
| | | | | | | | | | | | | | color. | | | color. | | | color. | | | color. | | | color. | | | | | | Drucktinte | Macrogol | 3350 | | | | | | | | | | Überzug | | 30 | | Propylenglycol | | | Talcum | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
002 | 112 | 9524.65 | 10080.10 | A | LS | Non |
|
|